Results From A Phase 1/2 Safety And Dose Escalation Study Of Tak-754, An Aav8 Vector With A Codon-Optimized B-Domain-Deleted Factor Viii Transgene In Severe Hemophilia A J. Chapin,G. Allen,M. T. Alvarez-Roman, M. Ayash-Rashkovsky,F. J. Lopez Jaime, C. Maggiore, M. E. Mingot-Castellano, K. Rajavel, A. Rauch,S. Susen, Y. Wang,B. EwensteinHAEMOPHILIA（2021）引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
